Banner

Lid and Lash

Latest News

Inflamed red eyelid due to Demodex blepharitis
Tarsus announces Xdemvy availability at pharmacies nationwide

August 24th 2023

Lotilaner ophthalmic solution 0.25% (Xdemvy) was approved by the FDA in July, making it the first and only approved treatment for Demodex blepharitis.

Demodex mite under microscope (Adobe Stock / Евгений Вершинин)
Demodex “tails”

July 27th 2023

Peeling and swelling on the eyelid of the human eye (Adobe Stock / oes)
BREAKING NEWS: FDA approves lotilaner ophthalmic solution 0.25% for treatment of Demodex blepharitis

July 25th 2023

March 30, 2021, Brazil. In this photo medical syringes is seen with National Health Surveillance Agency (Anvisa) logo displayed in the background. (Adobe Stock / Rafael Henrique)
TEPEZZA approved for treatment of TED in Brazil

June 28th 2023

AOA 2023: The diaries of Demodex
AOA 2023: The diaries of Demodex

June 23rd 2023

Video Interviews
Latest CME Events & Activities

(CME/CNE Credit) Community Practice Connections™: Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

View More

(COPE Credit) Community Practice Connections™: Comprehensive Key Advances in Biosimilars for Retinal Diseases – Reviewing the Evidence, Addressing Patient Perspectives, and Practice Utilization for the Retina Specialist

View More

Free COPE CE at AAOPT

Register Now!

Clinical Consultations: Individualizing Management of Uveitic Macular Edema - Clinical Updates in Treatment Options

View More

Enjoy these CME sessions at AAO 2023

Register Now!

C.R.U. Eye Symposium (Current, Relevant, Useful)

11/10/2023-11/12/2023

Register Now!

Community Practice Connections™: Ophthalmology and Oncology Perspectives on Integrating Novel Bispecific Antibodies Into the Uveal Melanoma Treatment Paradigm

View More

Medical Crossfire®: Ophthalmology and Oncology Perspectives on Integrating Novel Bispecific Antibodies Into the Uveal Melanoma Treatment Paradigm

View More

The Ophthalmology Times EyeCon 2023

Register Now!

The Optometry Times EyeCon 2023

Register Now!

(CME Credit) Community Practice Connections™: Expert Approaches in Cataract Surgery – Managing Advances in Techniques and Technologies With an Updated Armamentarium

View More

(COPE Credit) Community Practice Connections™: Expert Approaches in Cataract Surgery – Managing Advances in Techniques and Technologies With an Updated Armamentarium

View More

(CME/CNE Credit) MGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment Paradigm

View More

(COPE Credit) MGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment Paradigm

View More

(COPE Credit) Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED

View More

(CME/CNE Credit) Expert Illustrations & Commentaries™: Envisioning New Therapies for Meibomian Gland Dysfunction-Associated DED

View More

(CME Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

(COPE Credit) Patient, Provider, and Caregiver Connection™: Individualizing Care in Allergic Conjunctivitis – Understanding the Patient’s Perspective in Alleviating Disease Burden

View More

Expert Insights in Geographic Atrophy with Transformative Care on the Horizon – Understanding the Complement System as a Target for Treatment

View More

Community Practice Connections™: 2nd Annual Optometry Times™ EyeCon

View More

Shared Perspectives in Managing Presbyopia – Understanding a New Paradigm for Optimizing Quality of Life

View More

Perfecting Co-Management of Glaucoma – Utilizing Development in the Spectrum of Treatment Options

View More

Community Practice Connections™: Ophthalmology Times® EyeCon 2022

View More

Medical Crossfire®: Expert Perspectives in Geographic Atrophy – How Can We Prepare for a New Era of Treatment?

View More

(COPE Credit) Addressing Healthcare Inequities Diabetic Retinal Vascular Disease: How Can We Address Ethnic Disparities within the Clinic?

View More

(CME Credit) Addressing Healthcare Inequities Diabetic Retinal Vascular Disease: How Can We Address Ethnic Disparities within the Clinic?

View More

(COPE Credit) Community Practice Connections™: Improving Management of MGD-Associated Dry Eye Disease—A Look to the Future of Treatment

View More

(CME Credit) Community Practice Connection™: Paradigm Shifts in Presbyopia – Understanding Advances in Topical Treatment Innovations

View More

(CME/CNE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

(COPE Credit) Analyzing Novel Tear Stimulating Treatments for Special Populations in Dry Eye Disease

View More

More News

© 2023 MJH Life Sciences

All rights reserved.